PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Coal tar and corticosteroids
Presentation Product Chemical substance Chapter Items dispensed
Coal tar soln 10% / Salic acid 2% in Betameth val 0.1% oint
1305020I0AAAGAG
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin 1
Coal tar 10% in Hydrocortisone 1% cream
1305020I0AAANAN
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Coal tar 12%/Salicylic acid 2% in Hydrocortisone 1%
1305020I0AAAKAK
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Coal tar 2%/Salicylic acid 3% in Betamethasone valerate 0.1%
1305020I0AAALAL
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Coal tar 5%/Salicylic acid 5% in Betamethasone valerate 0.1%
1305020I0AAAMAM
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Coal tar 8%/Salicylic acid 2% in Betamethasone valerate 0.1%
1305020I0AAAFAF
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Coal tar soln 10% / Salic acid 5% in Betameth val 0.1% oint
1305020I0AAAHAH
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Coal tar soln 5% / Salic acid 5% in Betameth val 0.025% oint
1305020I0AAAJAJ
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Coal tar soln 5% /Salic acid 10% in Betameth val 0.025% oint
1305020I0AAAIAI
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available
Generic Alphosyl HC cream
1305020I0AAADAD
Coal tar and corticosteroids Coal tar and corticosteroid preparations Skin No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.